Literature DB >> 4629823

Doxycycline blood levels in normal subjects after intravenous and oral administration.

B J Leibowitz, J L Hakes, M M Cahn, E J Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4629823

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


× No keyword cloud information.
  6 in total

1.  Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline.

Authors:  A W Chow; V Patten; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

2.  Acute pelvic inflammatory disease and clinical response to parenteral doxycycline.

Authors:  A W Chow; K L Malkasian; J R Marshall; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

3.  Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.

Authors:  M Karlsson; S Hammers; I Nilsson-Ehle; A S Malmborg; B Wretlind
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis.

Authors:  L Dotevall; L Hagberg
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

5.  Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci.

Authors:  J N Minuth; T M Holmes; D M Musher
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

6.  Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations.

Authors:  J R Aeschlimann; M J Zervos; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.